---
title: Aldeyra Therapeutics vs Critical Path Institute
slug_a: aldeyra
slug_b: critical-path-institute
site: cro
review_signal_gate: closed
canonical_path: /compare/aldeyra/critical-path-institute
---

# Aldeyra Therapeutics vs Critical Path Institute

Side-by-side profile data from each company listing on this directory.

## Aldeyra Therapeutics

- Profile: [/companies/aldeyra](/companies/aldeyra)

Aldeyra Therapeutics — Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.

Services: 5. Modalities: 1. Indications: 3. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations
- US FDA Regulatory Strategy
- Immunology & Inflammation Services

### Modalities

- Small Molecule

### Indications

- Immunology
- Rare Disease
- Ophthalmology

### Phases

- Phase II
- Phase III

### Sourcing models

- Data not yet provided.

## Critical Path Institute

- Profile: [/companies/critical-path-institute](/companies/critical-path-institute)

Critical Path Institute — Critical Path Institute convenes pharmaceutical, government, patient, and academic organizations to optimize drug and medical product development through collaborative consortia, regulatory science initiatives, and clinical trial design optimization.

Services: 4. Modalities: 0. Indications: 4. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (4).

### Services

- Clinical Operations
- Regulatory Affairs
- US FDA Regulatory Strategy
- Translational Research

### Modalities

- Data not yet provided.

### Indications

- Immunology
- Neurology
- Metabolic
- Rare Disease

### Phases

- Phase I
- Phase II
- Phase III

### Sourcing models

- Data not yet provided.